✦ LIBER ✦

Adenovirus-mediated gene therapy in a mouse model of glycogen storage disease type 1a

✍ Scribed by Janice Chou; Adriana Zingone; Chi-Jiunn Pan

Publisher: Springer
Year: 2002
Tongue: English
Weight: 259 KB
Volume: 161
Category: Article
ISSN: 0340-6997
DOI: 10.1007/s00431-002-1005-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Novel mutation (G188R) in the G6Pase gen

Novel mutation (G188R) in the G6Pase gene of a patient with glycogen storage disease type 1a

✍ Pascale Trioche; Philippe Labrune; Michel Odièvre; Michelle Hedchouel; Jean-Fran 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB 👁 2 views

Germline mutations in the BRCAl gene confer susceptibility to hereditary breast and ovarian cancer (Easton et al., 1993; Ford et al., 1994). We report a new mutation in the BRCAl gene in an Austrian hereditary breast and ovarian cancer (HBOC) family with four breast cancer cases and one ovarian canc

Pathological features of glycogen storag

Pathological features of glycogen storage disease type II highlighted in the knockout mouse model

✍ Bijvoet, Agnes G. A.; Van Hirtum, Hans; Vermey, Marcel; Van Leenen, Dik; Van der 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 794 KB

Glycogen storage disease type II (GSDII; Pompe's disease) is an autosomal recessive disease caused by lysosomal -glucosidase deficiency. Skeletal muscle weakness is the most conspicuous clinical symptom of patients suffering from GSDII and skeletal muscle also is prominently involved in the knockout

Use of nonviral promoters in adenovirus-

Use of nonviral promoters in adenovirus-mediated gene therapy: reduction of lysosomal storage in the aspartylglucosaminuria mouse

✍ Salli Virta; Juhani Rapola; Anu Jalanko; Minna Laine 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB

## Abstract ## Background Aspartylglucosaminuria (AGU) is a lysosomal storage disease with severe neurodegenerative clinical features resulting from the deficiency of lysosomal aspartylglucosaminidase (AGA). The AGU knockout mouse is a good model to test different therapy strategies, as it mimics

Effect of continuous glucose therapy wit

Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type 1a glycogen storage disease

✍ David A. Weinstein; Joseph I. Wolfsdorf 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 94 KB

Plasmid-based gene transfer ameliorates

Plasmid-based gene transfer ameliorates visceral storage in a mouse model of Sandhoff disease

✍ Akira Yamaguchi; Kayoko Katsuyama; Kyoko Suzuki; Kenji Kosaka; Ichiro Aoki; Shoj 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 449 KB

Postnatal regression of glucose transpor

Postnatal regression of glucose transport in a patient with glycogen storage disease type 1b

✍ J. Levy; M. T. Abu-Ras; T. Berenstein; R. Potashnik; I. Meisner; S. W. Moses; N. 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 420 KB